The Cancer Breakthrough Boom
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
University of California San Francisco
Give to UCSF
Displaying 91 - 120 of 1079
-
-
Two UCSF Researchers Win Pew Awards for Biomedical Science
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
-
Breast Density and BMI Both Play a Role in Breast Cancer Risk
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is
-
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
-
Personalizing Prostate Cancer Screening May Improve Accuracy of Detection
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
-
Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
-
Transgender Women Benefit from Prostate Cancer Screenings
Transgender women keep their prostates even after gender-affirming surgery, and the estimated risk of prostate cancer is at about 14 cases per 10,000 people.
-
Transgender Women Face Prostate Cancer Risk, Says First-of-its-Kind Study From UCSF
-
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.
-
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF's Division of Surgical Oncology is currently the only center in Northern California offering surgical insertion of hepatic artery infusion (HAI) for patients.
-
Drug Resistance, Targeted Cell Therapies Among Cancer Conference Talks
Leading cancer researchers from UCSF will present at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 14-19, 2023, in Orlando.
-
Colon Cancer Rising Among Young Adults 20-49 Years Old: Here Are Their Stories
-
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
-
Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
-
California’s Anti-Smoking Push Spurs Big Savings on Health Costs
For the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.
-
New App Calculates Women’s Risk for Advanced Breast Cancer
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
-
Paid Sick Leave Means More People Get Screened for Cancer
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
-
Science World Honors Kevan Shokat for High-Impact Cancer Research
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
-
Plant-based Foods May Reduce Prostate Cancer Progression, Study Says
-
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
-
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
-
Breast Cancer Risk Calculator Can Assess Risk of Advanced Cancer
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
-
Big Little Lives
Trillions of invisible organisms make up the human microbiome. Now, medical scientists want to put these bugs to work.
-
The Radical Compassion of Awake Brain Surgery
On the operating table and inside the lab of a rising star in cancer neurosurgery.
-
Aggressive Surgery Increases Survival with Low-Grade Brain Tumors
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
-
UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
Researchers have discovered a cellular uptake pathway for larger molecules that delivers cell-permeable drugs efficiently.
-
Rethinking How Cancer Cells Evade Targeted Therapy
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
-
Killing Pancreatic Cancer with T Cells that Supercharge Themselves
T-cells can be directed to produce cytokine, a powerful anti-cancer component, when they encounter cancer cells. This holds tremendous promise for cancer immunotherapy.
-
International Hematologic Conference Features UCSF Health Experts
UCSF experts in multiple myeloma and other hematologic malignancies will attend the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
-
How AI Found the Words to Kill Cancer Cells
A new sophisticated machine learning technique using a molecular library of commands guides engineered immune cells to seek out and tirelessly kill cancer cells.
